CBARA1/MICU1 Monoclonal Antibody, APC-Cy5.5 Conjugated
Applications
Reactivity
Overview | |
Catalog # | bsm-33198M-APC-Cy5.5 |
Product Name | CBARA1/MICU1 Monoclonal Antibody, APC-Cy5.5 Conjugated |
Applications | WB |
Reactivity | Human, Mouse, Rat |
Specifications | |
Conjugation | APC-Cy5.5 |
Host | Mouse |
Source | Recombinant human CBARA1 Protein (1-250/476) |
Clonality | Monoclonal |
Clone # | 1H8 |
Isotype | IgG |
Concentration | 1ug/ul |
Purification | Purified by Protein G. |
Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target | |
Gene ID | 10367 |
Swiss Prot | Q9BPX6 |
Subcellular location | Cytoplasm |
Synonyms | Mitochondrial Calcium Uptake 1; Calcium-Binding Atopy-Related Autoantigen 1; Atopy-Related Autoantigen CALC; Ara CALC; CBARA1; CALC; Calcium Binding Atopy-Related Autoantigen 1; Calcium Uptake Protein 1, Mitochondrial; Allergen Hom S 4; EFHA3; MPXPS; MICU1_HUMAN; |
Background | Key regulator of mitochondrial calcium uniporter (MCU) that senses calcium level via its EF-hand domains (PubMed:20693986, PubMed:23101630, PubMed:23747253, PubMed:24313810, PubMed:24332854, PubMed:24503055, PubMed:24560927, PubMed:26341627, PubMed:26903221, PubMed:27099988). MICU1 and MICU2 form a disulfide-linked heterodimer that stimulates and inhibits MCU activity, depending on the concentration of calcium. MICU1 acts both as an activator or inhibitor of mitochondrial calcium uptake (PubMed:26903221). Acts as a gatekeeper of MCU at low concentration of calcium, preventing channel opening (PubMed:26903221). Enhances MCU opening at high calcium concentration, allowing a rapid response of mitochondria to calcium signals generated in the cytoplasm (PubMed:24560927, PubMed:26903221). Regulates glucose-dependent insulin secretion in pancreatic beta-cells by regulating mitochondrial calcium uptake (PubMed:22904319). Induces T-helper 1-mediated autoreactivity, which is accompanied by the release of IFNG (PubMed:16002733). |
Application Dilution | |
WB | 1:300-5000 |